A "mitochondrial cascade hypothesis" for sporadic Alzheimer's disease

Medical Hypotheses

Volumn 63, Issue 1, 2004, Pages 8-20

  Swerdlow, Russell H ^a   Khan, Shaharyar M ^a,b  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b Gencia Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; AMYLOID PROTEIN; LIPID; MITOCHONDRIAL DNA; MITOCHONDRIAL RNA; REACTIVE OXYGEN METABOLITE; TAU PROTEIN;

AGING; ALZHEIMER DISEASE; ANEUPLOIDY; APOPTOSIS; AUTOSOMAL DOMINANT INHERITANCE; BETA SHEET; BRAIN MITOCHONDRION; CELL CYCLE; HISTOPATHOLOGY; HUMAN; HYPOTHESIS; MITOCHONDRIAL DNA DISORDER; NERVE CELL; NEUROFIBRILLARY TANGLE; NONHUMAN; OXIDATION REDUCTION REACTION; PATHOPHYSIOLOGY; PRESENILE DEMENTIA; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN PHOSPHORYLATION; RESPIRATORY CHAIN; REVIEW; SENILE DEMENTIA; STEM CELL;

EID: 3042806534     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2003.12.045     Document Type: Article

References (188)

1. Alzheimer A. Uber eine eigenartige Erkrankung der Hirnrinde. Allg. Z. Psychiat. Psych- Gerichtl. Med. 64:1907;146-148
2. Kraepelin E. Psychiatrie. Ein Lehrbuch fur Studierende und Artze. II. Band, Klinische Psychiatrie. 1910;Verlag Johann Ambrosius Barth, Leipzig
3. Fischer O. Miliare Nekrosen mit drusigen Wucherungen der Neurofibrillen, eine regelmabige Veranderung der Hirnrinde bei seniler Demenz. Monatsschr. Psychiatr. Neurol. 22:1907;361-372
4. Perusini G. Sul valore nosografico di alcuni reperti istopatlogici caratteristici per la senilita. Rivista italiana di Neuropatologia. Psichiatria e Elettroterapia. 4:1911;145-151
5. Boller F., Forbes M.M. History of dementia and dementia in history: an overview. J. Neurol. Sci. 158:1998;125-133
6. Amaducci L.A., Rocca W.A., Schoenberg B.S. Origin of the distinction between Alzheimer's disease and senile dementia: how history can clarify nosology. Neurology. 36:1986;1497-1499
7. Katzman R. The prevalence and malignancy of Alzheimer's disease: a major killer. Arch. Neurol. 33:1976;217-218
8. Katzman R., Terry R., Bick K. Recommendations of the nosology, epidemiology, and etiology and pathophysiology commissions of the workshop-conference on Alzheimer's disease: senile dementia and related disorders. Katzman R., Terry R.D., Bick K.L. Alzheimer's disease: senile dementia and related disorders. 1978;579-585 Raven Press, New York
9. Katzman R. Alzheimer's disease. New England J. Med. 314:1986;964-973
10. Amaducci L., Rocca W., Schoenberg B. Origin of the distinction between Alzheimer's disease and senile dementia. How history can clarify nosology. Neurology. 36:1986;1497-1499
11. Goate A., Chartier-Harlin M.C., Mullan M., Brown J., Crawford F., Fidani L., et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature. 349:1991;704-706
12. Sherrington R., Rogaev E.I., Liang Y., Rogaeva E.A., Levesque G., Ikeda M., et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature. 375:1995;754-760
13. Levy-Lahad E., Wasco W., Poorkaj P., Romano D.M., Oshima J., Pettingell W.H., et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science. 269:1995;973-977
14. Hardy J., Allsop D. Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmacol. Sci. 12:1991;383-388
15. Hardy J.A., Higgins G.A. Alzheimer's disease: the amyloid cascade hypothesis. Science. 256:1992;184-185
16. Selkoe D.J. Cell biology of the amyloid. β -protein precursor and the mechanism of Alzheimer's disease Annu. Rev. Cell. Biol. 10:1994;373-403
17. Selkoe D.J. Toward a comprehensive theory for Alzheimer's disease. Ann. NY Acad. Sci. 924:2000;17-25
18. Cummings J.L., Cole G. Alzheimer disease. JAMA. 287:2002;2335-2338
19. Swerdlow R.H., Kish S.J. Mitochondria in Alzheimer's disease. Int. Rev. Neurobiol. 53:2002;341-385
20. Davis D.G., Schmitt F.A., Wekstein D.R., Markesbery W.R. Alzheimer neuropathologic alterations in aged cognitively normal subjects. J. Neuropath. Exp. Neurol. 58:1999;376-388
21. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Lancet. 357:2001;169-175
22. Snowdon D.A. Healthy aging and dementia: findings from the nun study. Ann. Int. Med. 139:2003;450-454
23. Barinaga M. Is apoptosis key in Alzheimer's disease. Science. 281:1998;1303-1304
24. Arendt T. Alzheimer's disease as a loss of differentiation control in a subset of neurons that retain immature features in the adult brain. Neurobiol. Aging. 21:2000;783-796
25. Yang Y., Geldmacher D.S., Herrup K. DNA replication precedes neuronal cell death in Alzheimer's disease. J. Neurosci. 21:2001;2662-2668
26. Anderton B.H. Ageing of the brain. Mech. Ageing and Dev. 123:2002;811-817
27. Kwon Y.W., Masutani H., Nakamura H., Ishii Y., Yodoi J. Redox regulation of cell growth and cell death. Biol. Chem. 384:2003;991-996
28. Fulco M., Schiltz R.L., Iezzi S., King M.T., Zhao P., Kashiwaya Y., et al. Sir2 regulates skeletal muscle differentiation as a potential sensor of the redox state. Mol. Cell. 12:2003;51-62
29. Chueh P.J. Cell membrane redox systems and transformation. Antioxid. Redox Signal. 2:2000;177-187
30. Klein J.A., Ackerman S.L. Oxidative stress, cell cycle, and neurodegeneration. J. Clin. Invest. 111:2002;785-793
31. Boveris A., Oshino N., Chance B. The cellular production of hydrogen peroxide. Biochem. J. 128:1972;617-630
32. Chance B., Sies H., Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol. Rev. 59:1979;527-605
33. Shigenaga M.K., Hagen T.M., Ames B.N. Oxidative damage and mitochondrial decay in aging. Proc. Natl. Acad. Sci. USA. 91:1994;10771-10778
34. Burdon R.H. Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Rad. Biol. Med. 18:1995;775-794
35. Johansson C.B. Mechanism of stem cells in the central nervous system. J. Cell. Physiol. 196:2003;409-418
36. Jauniaux E., Gulbis B., Burton G.J. The human first trimester gestational sac limits rather than facilitates oxygen transfer to the foetus - A review. Placenta. 24(suppl A):2003;S86-S93
37. Nasr-Esfahani M.H., Aitken J.R., Johnson M.H. Hydrogen peroxide levels in mouse oocytes and early cleavage stage embryos developed in vitro or in vivo. Development. 109:1990;501-507
38. Johnson M.H., Nasr-Esfahani M.H. Radical solutions and cultural problems: could free oxygen radicals be responsible for the impaired development of preimplantation mammalian embryos in vitro. Bioessays. 16:1994;31-38
39. Trimarchi J.R., Liu L., Porterfield D.M., Smith P.J.S., Keefe D.L. Oxidative phosphorylation-dependent and - independent oxygen consumption by individual preimplantation mouse embryos. Biol. Reprod. 62:2000;1866-1874
40. Sweet S., Singh G. Accumulation of human promyelocytic leukemic (HL-60) cells at two energetic cell cycle checkpoints. Cancer Res. 55:1995;5164-5167
41. Dorward A., Sweet S., Moorehead R., Singh G. Mitochondrial contributions to cancer cell physiology: redox balance, cell cycle, and drug resistance. J. Bioenerg. Biomem. 29:1997;385-392
42. Lovestone S., Reynolds C.H. The phosphorylation of tau: a critical stage in neurodevelopment and neurodegenerative processes. Neuroscience. 78:1997;309-324
43. Connolly J.A., Kalnins V.I., Cleveland D.W., Kirschner M.W. Immunoflourescent staining of cytoplasmic and spindle microtubules in mouse fibroblasts with antibody to tau protien. Proc. Natl. Acad. Sci. USA. 74:1977;2437-2440
44. Delobel P., Plament S., Hamdane M., Mailliot C., Sambo A.V., Begard S., et al. Abnormal tau phosphorylation of the Alzheimer-type also occurs during mitosis. J. Neurochem. 83:2002;412-420
45. Billingsley M.L., Kincaid R.L. Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration. Biochem. J. 323:1997;577-591
46. Hartigan J.A., Johnson G.V.W. Tau protein in normal and Alzheimer's disease brain: an update. Alzheimer's Disease Rev. 3:1998;125-141
47. Trounce I., Byrne E., Marzuki S. Decline in skeletal muscle mitochondrial respiratory chain function: possible factor in ageing. Lancet. 1:1989;637-639
48. Yen T.C., Chen Y.S., King K.L., Yeh S.H., Wie Y.H. Liver mitochondrial respiratory function declines with age. Biochem. Biophys. Res. Commun. 165:1989;994-1003
49. Cooper J.M., Mann V.M., Schapira A.H.V. Analysis of mitochondrial respiratory cahin function and mitochondrial DNA deletion in human skeletal muscle: effect of aging. J. Neurol. Sci. 113:1992;91-98
50. Ojaimi J., Masters C.L., Opwskin K., McKelvie P., Byrne E. Mitochondrial respiratory chain activity in the human brain as a function of age. Mech. Ageing Dev. 111:1999;39-47
51. Harmon D. The biologic clock: the mitochondria. J. Am. Geriatr. Soc. 20:1972;145-147
52. Miquel J., Economos A.D., Fleming J., Johnson J.E. Mitochondrial role in cell aging. Exp. Gerontol. 15:1980;575-591
53. Beckman K.B., Ames B.N. Mitochondrial aging: open questions. Ann. NY Acad. Sci. 854:1998;118-127
54. Melov S. Mitochondrial oxidative stress. Physiologic consequences and potential for a role in aging. Ann. NY Acad. Sci. 908:2000;219-225
55. Lenaz G., Bovina C., D'Aurelio M., Fato R., Formiggini G., Genova M.L., et al. Role of mitochondria in oxidative stress and aging. Ann. NY Acad. Sci. 959:2002;199-213
56. Cadenas E., Davies K.J.A. Mitochondrial free radical generation, oxidative stress, and aging. Free Rad. Biol. Med. 29:2000;222-230
57. Linnane A.W., Marzuki S., Ozawa T., Tanaka M. Mitochondrial DNA mutations as an important contributor to ageing and degenerative diseases. Lancet. 1:1989;642-645
58. Wallace D.C. Mitochondrial genetics: a paradigm for aging and degenerative diseases? Science. 256:1992;628-632
59. Beckman K.B., Ames B.N. The free radical theory of aging matures. Physiol. Rev. 78:1998;548-581
60. Gadaleta M.N., Cormio A., Pesce V., Lezza A.M., Cantatore Aging and mitochondria. Biochimie. 80:1998;863-870
61. Ozawa T. Mechanism of somatic mitochondrial DNA mutations associated with age and diseases. Biochim. Biophys. Acta. 1271:1995;177-189
62. Melov S., Shoffner J.M., Kaufman A., Wallace D.C. Marked increase in the number and variety of mitochondrial DNA rearrangements in aging human skeletal muscle. Nucl. Acids Res. 23:1995;4122-4126
63. Kovalenko S.A., Kopsidas G., Kelso J.M., Linnane A.W. Deltoid human muscle mtDNA is extensively rearranged in old age subjects. Biochem. Biophys. Res. Commun. 232:1997;147-152
64. Melov S., Schneider J.A., Coskun P.E., Bennett D.A., Wallace D.C. Mitochondrial DNA rearrangements in aging human brain in situ PCR of mtDNA. Neurobiol. Aging. 20:1999;565-571
65. Michikawa Y., Mazzucchelli F., Bresolin N., Scarlato G., Attardi G. Aging-dependent large accumulation of point mutations in the human mtDNA control region for replication. Science. 286:1999;774-779
66. Wang Y., Michikawa Y., Mallidis C., Bai Y., Woodhouse K.E., Yarasheski K.E., et al. Muscle-specific mutations accumulate with aging in critical human mtDNA control sites for replication. Proc. Natl. Acad. Sci. USA. 98:2001;4022-4027
67. Lin M.T., Simon D.K., Ahn C.H., Kim L.M., Beal M.F. High aggregate burden of somatic mtDNA point mutations in aging and Alzheimer's disease brain. Hum. Mol. Genet. 11:2002;133-145
68. Richter C., Park J.W., Ames B.N. Normal oxidative damage to mitochondrial and nuclear DNA is extensive. Proc. Natl. Acad. Sci. USA. 85:1988;6465-6467
69. Cheng K.C., Cahill D.S., Kasai H., Nishimura S., Loeb L.A. 8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G-T and A-C substitutions. J. Biol. Chem. 267:1992;166-172
70. Brierley E.J., Johnson M.A., James O.F., Turnbull D.M. Mitochondrial involvement in the ageing process. Facts and controversies. Mol. Cell. Biochem. 174:1997;325-328
71. Yoneda M., Chomyn A., Martinuzzi A., Hurko O., Attardi G. Marked replicative advantage of human mtDNA carrying a point mutation that causes the MELAS encephalomyopathy. Proc. Natl. Acad. Sci. USA. 89:1992;11164-11168
72. Taylor D.R., Zeyl C., Cooke E. Conflicting levels of selection in the accumulation of mitochondrial defects in Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. USA. 99:2002;3690-3694
73. De Grey A.D.N.J. A mechanism proposed to explain the rise in oxidative stress during aging. J. Anti. Aging Med. 1:1998;53-66
74. Kowald A. The mitochondrial theory of aging: do damaged mitochondria accumulated by delayed degradation? Exp. Gerontol. 34:1999;605-612
75. Gershon D. The mitochondrial theory of aging: is the culprit a faulty disposal system rather than indigenous mitochondrial alterations. Exp. Gerontol. 34:1999;613-619
76. Soohal R.S., Agarwal A., Agarwal S., Orr W.C. Simultaneous overexpression of copper- and zinc-containing superoxide dismutase and catalase retards age-related oxidative damage and increases metabolic potential in Drosophila melanogaster. J. Biol. Chem. 270:1995;15671-15674
77. Roth G.S., Ingram D.K., Lane M.A. Slowing ageing by caloric restriction. Nat. Med. 1:1995;414-415
78. Aspnes L.E., Lee C.M., Weindruch R., Chung S.S., Roecker E.B., Aiken J.M. Caloric restriction reduces fiber loss and mitochondrial abnormalities in aged rat muscle. FASEB J. 11:1997;573-581
79. Zamzami N., Hirsch T., Dallaporta B., Petit P.X., Kroemer G. Mitochondrial implication in accidental and programmed cell death: apoptosis and necrosis. J. Bioenerg. Biomem. 29:1997;185-193
80. Ichas F., Mazat J.P. From calcium signaling to cell death: two conformations for the mitochondrial permeability transition pore. Switching from low- to high-conductance state. Biochim. Biophys. Acta. 1366:1998;33-50
81. Zou H., Li Y., Liu X., Wang X. An APAF-1 cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J. Biol. Chem. 27:1999;11549-11556
82. Liu X., Naekyung Kim C., Yang J., Jemmerson R., Wang X. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell. 86:1996;147-157
83. Kluck R.M., Bossy-Wetzel E., Green D.R., Newmeyer D.D. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science. 275:1997;1132-1136
84. Petit P.X., Zamzami N., Vayssiere J.L., Mignotte B., Kroemer G., Castedo M. Implication of mitochondria in apoptosis. Mol. Cell. Biochem. 174:1997;185-188
85. Yang J., Liu X., Bhalla K., Kim C.N., Ibrado A.M., Cai J., et al. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science. 275:1997;1129-1132
86. Li P., Nijhawan D., Budihardjo I., Srinivasula S.M., Ahmad M., Alnemri E.S., et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell. 91:1997;479-489
87. Cardoso S.M., Swerdlow R.H., Oliveira C.R. Induction of cytochrome c-mediated apoptosis by amyloid. β 25-35 requires functional mitochondria Brain Res. 931:2002;117-125
88. Negre-Salvayre A., Hirtz C., Carrera G., Cazenave R., Troly M., Salvayre R., et al. A role for uncoupling proteins-2 as a regulator of mitochondrial hydrogen peroxide generation. FASEB J. 11:1997;809-815
89. Ledesma A., de Lacoba M.G., Rial E. The mitochondrial uncoupling proteins. Genome Biol. 3:2003;3015. Reviews
90. Anandtheerthavarada H.K., Biswas G., Robin M.A., Avadhani M.G. Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's precursor protein impairs mitochondrial function in neuronal cells. J. Cell. Biol. 16:2003;41-54
91. Dyall S.D., Lester D.C., Schneider R.E., Delgadillo_correa M.G., Plumper E., Martinez A., Koehler C.M., Johnson P.J. Trichomonas vaginalis Hmp35, a putative pore-forming hydrogenosomal membrane protein, can form a complex in yeast mitochondria. J. Biol. Chem. 278:2003;30548-30561
92. Robinson S.R., Bishop G.M. Abeta as a bioflocculant: implications for the amyloid hypothesis of Alzheimer's disease. Neurobiol. Aging. 23:2002;1051-1072
93. Atwood C.S., Moir R.D., Huang X., Scarpa R.C., Bacarra N.M., Romano D.M., et al. Dramatic aggregation of Alzheimer abeta by Cu (II) is induced by conditions representing physiological acidosis. J. Biol. Chem. 273:1998;12817-12826
94. Cardoso S.M., Santos S., Swerdlow R.H., Oliveira C.R. Functional mitochondria are required for amyloid beta-mediated neurotoxicity. FASEB J. 15:2001;1439-1441
95. Arias C., Montiel T., Quiroz-Baez R., Massieu L. β -Amyloid neurotoxicity is exacerbated during glycolysis inhibition and mitochondrial impairment in the rat hippocampus in vivo and in isolated nerve terminals: implications for Alzheimer's disease Exp. Neurol. 176:2002;163-174
96. Nunomura A., Perry G., Pappolla M.A., Wade R., Hirai K., Chiba S., et al. RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease. J. Neurosci. 19:1999;1959-1964
97. Smith M.A., Nunomura A., Zhu X., Takeda A., Perry G. Metabolic, metallic, and mitotic sources of oxidative stress in Alzheimer disease. Antioxide. Redox Signal. 2:2000;413-420
98. Shan X., Tashiro H., Lin C.L. The identification and characterization of oxidized RNAs in Alzheimer's disease. J. Neurosci. 23:2003;4913-4921
99. Sylvestre J., Vialette S., Corral Debrinski M., Jacq C. Long mRNAs coding for yeast mitochondrial proteins of prokaryotic origin preferentially localize to the vicinity of mitochondria. Genome Biol. 4:2003;R44. Epub 2003 Jun 06
100. Marc P., Margeot A., Devaux F., Blugeon C., Corral-Debrinski M., Jacq C. Genome-wide analysis of mRNAs targeted to yeast mitochondria. EMBO Rep. 3:2002;159-164. Epub 2002 Jan 29
101. Ginsberg M.D., Feliciello A., Jones J.K., Avvedimento E.V., Gottesman M.E. PKA-dependent binding of mRNA to the mitochondrial AKAP121 protein. J. Mol. Biol. 327:2003;885-897
102. Lawen A., Martinus R.D., McMullen G.L., Nagley P., Vaillant F., Wolvetang E.J., et al. The universality of bioenergetic disease: the role of mitochondrial mutation and the putative inter-relationship between mitochondria and plasma membrane NADH oxidoreductase. Molec. Aspects Med. 15(suppl):1994;s13-s27
103. 0 cells. J. Biol. Chem. 269:1994;30097-30100
104. Morre D.M., Lenaz G., Morre J. Surface oxidase and oxidative stress propagation in aging. J. Exp. Biol. 203:2000;1513-1521
105. Capuano F., Guerrieri F., Papa S. Oxidative phosphorylation enzymes in normal and neoplastic cell growth. J. Bioenerg. Biomembr. 29:1997;379-384
106. Chueh P.J. Cell membrane redox systems and transformation. Antioxid. Redox Signal. 2:2000;177-187
107. Capuano F., Varone D., D'Eri N., Russo E., Tommasi S., Montemurro S., et al. Oxidative phosphorylation and F (O)F (1) ATP synthase activity of human hepatocellular carcinoma. Biochem. Mol. Biol. Int. 38:1996;1013-1022
108. Uriel J. Retrodifferentiation and the fetal patterns of gene expression in cancer. Adv. Cancer Res. 29:1979;127-174
109. MITOMAP: A Human Mitochondrial Genome Database. Center for Molecular Medicine, Emory University, Atlanta, GA, USA. Available from: http://www.gen.emory.edu/mitomap.html, 2001
110. National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health. Available from: http://www.ncbi.nlm. nih.gov/entrez/, 2002
111. Roubertoux P.L., Sluyter F., Carlier M., Marcet B., Maarouf-Veray F., Cherif C., et al. Mitochondrial DNA modifies cognition in interaction with the nuclear genome and age in mice. Nat. Genet. 35:2003;65-69
112. De Benedictis G., Rose G., Carrieri G., De Luca M., Falcone E., Passarino G., et al. Mitochondrial DNA inherited variants are associated with successful aging and longevity in humans. FASEB J. 13:1999;1532-1536
113. Tanaka M., Gong J.S., Zhang J., Yoneda M., Yagi K. Mitochondrial gentoype associated with longevity. Lancet. 351:1998;185-186
114. van der Walt J.M., Nicodemus K.K., Martin E.R., Scott W.K., Nance M.A., Watts R.L., et al. Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease. Am. J. Hum. Genet. 72:2003;804-811
115. Wolin M.S. Reactive oxygen species and vascular signal transduction mechanisms. Microcirculation. 3:1996;1-17
116. Droge W. Free radicals in the physiologic control of cell function. Physiol. Rev. 82:2001;47-95
117. Wanagat J., Cao Z., Pathare P., Aiken J.M. Mitochondrial DNA deletion mutations colocalize with segmental electron transport system abnormalities, muscle fiber atrophy, fiber splitting, and oxidative damage in sarcopenia. FASEB J. 15:2001;322-332
118. Fayet G., Jansson M., Sternberg D., Moslemi A.R., Blondy P., Lombes A., et al. Aging muscle: clonal expansions of mitochondrial DNA point mutations and deletions cause focal impairment of mitochondrial function. Neuromuscul. Disord. 12:2002;483-493
119. Chomyn A., Attardi G. MtDNA mutations in aging and apoptosis. Biochem. Biophys. Res. Commun. 304:2003;519-529
120. Mattson M.P., Liu D. Energetics and oxidative stress in synaptic plasticity and neurodegenerative disorders. Neuromol. Med. 2:2002;215-231
121. Brand F.N., Kiely D.K., Kannel W.B., Myers R.H. Family patterns of coronary heart disease mortality: the Framingham longevity study. J. Clin. Epidemiol. 45:1992;169-174
122. Duara R., Lopez-Alberola R.F., Barker W.W., Loewenstein D.A., Zatinsky M., Eisdorfer C.E., et al. A comparison of familial and sporadic Alzheimer's disease. Neurology. 43:1993;1377-1384
123. Edland S.D., Silverman J.M., Peskind E.R., Tsuang D., Wijsman E., Morris J.C. Increased risk of dementia in mothers of Alzheimer's disease cases: evidence for maternal inheritance. Neurology. 47:1996;254-256
124. Swerdlow R.H., Parker W.D., Currie L.J., Bennett J.P. Jr., Harrison M.B., Trugman J.M., et al. Gender ratio differences between Parkinson's disease patients and their affected parents. Parkinsonism Related Disorders. 7:2001;47-51
125. King M.P., Attardi G. Human cells lacking mtDNA: repopulation with exogenous mitochondria complementation. Science. 246:1989;500-503
126. Chomyn A., Lai S.T., Shakeley R., Bresolin N., Scarlato G., Attardi G. Platelet-mediated transformation of mtDNA-less human cells: analysis of phenotypic variability among clones from normal individuals - and complementation behavior of the tRNALys mutation causing myoclonic epilepsy and ragged red fibers. Am. J. Hum. Genet. 54:1994;966-974
127. Swerdlow R.H. Mitochondrial DNA and dysfunction in neurodegenerative diseases. Arch. Path. Lab. Med. 126:2002;271-280
128. Swerdlow R.H., Parks J.K., Miller S.W., Tuttle J.B., Trimmer P.A., Sheehan J.P., et al. Origin and functional consequences of the complex I defect in Parkinson's disease. Ann. Neurol. 40:1996;663-671
129. Gu M., Cooper J.M., Taanman J.W., Schapira A.H.V. Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease. Ann. Neurol. 44:1998;177-186
130. Shults C.W., Miller S.W. Reduced complex I activity in Parkinsonian cybrids. Mov. Dis. 13:1998;217
131. Davis R.E., Miller S., Herrnstadt C., Ghosh S.S., Fahy E., Shinobu L.A., et al. Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer disease. Proc. Natl. Acad. Sci. USA. 94:1997;4526-4531
132. Swerdlow R.H., Parks J.K., Cassarino D.S., Maguire D.J., Maguire R.S., Bennett J.P., et al. Cybrids in Alzheimer's disease: a cellular model of the disease. Neurology. 49:1997;918-925
133. Cassarino D.S., Fall C.P., Swerdlow R.H., Smith T.S., Halvorsen E.M., Miller S.W., et al. Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease. Biochim. Biophys. Acta. 1362:1997;77-86
134. Swerdlow R.H., Parks J.K., Davis J.N., Cassarino D.S., Trimmer P.A., Currie L.J., et al. Matrilineal inheritance of complex I dysfunction in a multigenerational Parkinson's disease family. Ann. Neurol. 44:1998;873-881
135. Ghosh S.S., Swerdlow R.H., Miller S.W., Sheeman B., Parker W.D. Jr., Davis R.E. Use of cytoplasmic hybrid lines for elucidating the role of mitochondrial dysfunction in Alzheimer's disease and Parkinson's disease. Ann. NY Acad. Sci. 893:2000;176-191
136. Swerdlow R.H., Miller S.W., Parks J.K., Sheehan J.P., Cassarino D.S., Maguire D.J., et al. Mitochondria in sporadic amyotrophic lateral sclerosis. Exp. Neurol. 153:1998;135-142
137. Swerdlow R.H., Golbe L.I., Parks J.K., Cassarino D.S., Binder D.R., Grawey A.E., et al. Mitochondrial dysfunction in cybrid lines expressing mitochondrial genes from patients with PSP. J. Neurochem. 75:2000;1681-1684
138. Trimmer P.A., Keeney P.M., Borland M.K., Simon F.A., Almeida J., Swerdlow R.H., et al. Mitochondrial abnormalites in cybrid cell models of sporadic Alzheimer's disease worsen with passage in culture. Neurobiol Dis. 15:2004;29-39
139. Cardoso SM, Santana I, Swerdlow RH, Oliveira CR. Mitochondria dysfunction of Alzheimer's disease cybrids enchances A β toxicity. J Neurochem, in press
140. Sheehan J.P., Swerdlow R.H., Parker W.D., Miller S.W., Davis R.E., Tuttle J.B. Altered calcium homeostasis in cells transformed by mitochondria from individuals with Parkinson's disease. J. Neurochem. 68:1997;1221-1233
141. Sheehan J.P., Swerdlow R.H., Miller S.W., Davis R.E., Tuttle J.B. Altered calcium homeostasis and reactive oxygen species production in cells transformed by Alzheimer's disease mitochondrial DNA. J. Neurosci. 17:1997;4612-4622
142. Cassarino D.S., Halvorsen E.M., Swerdlow R.H., Abramova N.N., Parker W.D., Sturgill T.W., et al. Interaction among mitochondria, mitogen-activated protein kinases, and nuclear factor-kappa B in cellular models of Parkinson's disease. J. Neurochem. 74:2000;1384-1392
143. Trimmer P.A., Swerdlow R.H., Parks J.K., Miller S.W., Davis R.E., Parker W.D. Jr. Abnormal mitochondrial morphology in sporadic Parkinson's and Alzheimer's disease cybrid lines. Exp. Neurol. 162:2000;37-50
144. L proteins in SH-SY5Y neuroblastoma and in Parkinson's disease cybrid cell lines. J. Neurosci. Res. 61:2000;693-700
145. Cassarino D.S., Swerdlow R.H., Parks J.K., Davis W.P. Jr., Bennett J.P. Jr. Cyclosporin A increases resting mitochondrial membrane potential in SY5Y cells and reverses the depressed mitochondrial membrane potential of Alzheimer's disease cybrids. Biochem. Biophys. Res. Commun. 248:1998;168-173
146. Khan S.M., Cassarino D.S., Abramova N.N., Keeney P.M., Borland K., Trimmer P.A., et al. Alzheimer's disease cybrids replicate. β -amyloid abnormalities through cell death pathways Ann. Neurol. 48:2000;148-155
147. 2 and modulation by glutathione in human neuroblastoma and Alzheimer's disease cybrid cells. Brain Res. Mol. Brain Res. 71:1999;69-77
148. De Sarno P., Bijur G.N., Lu R., Davis R.E., Jope R.S. Alterations in muscarinic receptor-coupled phosphoinositide hydrolysis and AP-1 activation in Alzheimer's disease cybrid cells. Neurobiol. Aging. 21:2000;31-38
149. Trimmer P.A., Borland K., Keeney P.M., Bennett J.P. Jr., Parker W.D. Jr. Parkinson's disease transgenic mitochondrial cybrids generate Lewy inclusion bodies. J Neurochem. 88:2004;800-812
150. Laderman K.A., Penny J.R., Mazzucchelli F., Bresolin N., Scarlato G., Attardi G. Aging-dependent functional alterations of mitochondrial DNA (mtDNA) from human fibroblasts transferred into mtDNA-less cells. J. Biol. Chem. 271:1996;15891-15897
151. Diaz F., Bayona-Bafaluy M.P., Rana M., Mora M., Hao H., Moraes C.T. Human mitochondrial DNA with large deletions repopulates organelles faster than full-length genomes under relaxed copy number control. Nucl. Acids Res. 30:2002;4626-4633
152. Cortopassi G.A., Arnheim N. Detection of a specific mitochondrial DNA deletion in tissues of older humans. Nucl. Acids Res. 18:1990;6927-6933
153. Cortopassi G.A., Shibata D., Soong N.W., Arnheim N. A pattern of accumulation of a somatic deletion of mitochondrial DNA in aging human tissues. Proc. Natl. Acad. Sci. USA. 89:1992;7370-7374
154. Soong N.W., Hinton D.R., Cortopassi G., Arnheim N. Mosaicism for a specific somatic mitochondrial DNA mutations in adult human brain. Nat. Genet. 2:1992;318-323
155. Corral-Debrinski M., Horton M.T., Lott J.M., Shoffner J.M., Beal M.F., Wallace D.C. Mitochondrial DNA deletions in human brain: regional variability and increase with advanced age. Nat. Genet. 2:1992;324-329
156. Corral-Debrinski M., Horton T., Lott M.T., Shoffner J.M., McKee A.C., Beal M.F., et al. Marked changes in mitochondrial DNA deletion levels in Alzheimer brains. Genomics. 23:1994;471-476
157. Smigrodzki R, Parks J, Parker WD. High frequency of mitochondrial complex I mutations in Parkinson's disease and aging. Neurobiol Aging, in press
158. Elson J.L., Samuels D.C., Turnbull D.M., Chnnery P.F. Random intracellular drift explains the clonal expansion of mitochondrial DNA mutations with age. Am. J. Hum. Genet. 68:2001;802-806
159. Nekhaeva E., Bodyak N.D., Kraytsberg Y., McGrath S.B., Van Orsouw N.J., Pluzhnikov A., et al. Clonally expanded mtDNA point mutations are abundant in individual cells in human tissues. Proc. Natl. Acad. Sci. USA. 99:2002;5521-5526
160. Coller H.A., Bodyak N.D., Khrapko K. Frequent intracellular clonal expansions of somatic mtDNA mutations. Ann. NY Acad. Sci. 959:2002;434-447
161. Muller-Hocker J. Cytochrome-c-oxidase deficient cardiomyocytes in the human heart - an age-related phenomenon. A histochemical ultracytochemical study. Am. J. Pathol. 134:1989;1167-1173
162. Muller-Hocker J., Schneiderbanger K., Stefani F.H., Kadenbach B. Progressive loss of cytochrome c oxidase in the human extraocular muscles in ageing - a cytochemical-immunohistochemical study. Mutat. Res. 275:1992;115-124
163. Trounce I., Byrne E., Marzuki S. Decline in skeletal muscle mitochondrial respiratory chain function: possible factor in ageing. Lancet. 1:1989;637-639
164. Yen T.C., Chen Y.S., King K.L., Yeh S.H., Wei Y.H. Liver mitochondrial respiratory functions decline with age. Biochem. Biophys. Res. Commun. 165:1989;944-1003
165. Bowling A.C., Mutisya E.M., Walker L.C., Price D.L., Cork L.C., Beal M.F. Age-dependent impairment of mitochondrial function in primate brain. J. Neurochem. 60:1993;1964-1967
166. Greco M., Villani G., Mazzucchelli F., Bresolin N., Papa S., Attardi G. Marked aging-related decline in efficiency of oxidative phosphorylation in human skin fibroblasts. FASEB J. 17:2003;1706-1708
167. Cooper J.M., Mann V.M., Schapira A.H.V. Analysis of mitochondrial respiratory cahin function and mitochondrial DNA deletion in human skeletal muscle: effect of aging. J. Neurol. Sci. 113:1992;91-98
168. Ojaimi J., Masters C.L., Opwskin K., McKelvie P., Byrne E. Mitochondrial respiratory chain activity in the human brain as a function of age. Mech. Ageing Dev. 111:1999;39-47
169. Papa S. Mitochondrial oxidative phosphorylation changes in the life span. Molecular aspects and physiopathological implications. Biochim. Biophys. Acta. 1276:1996;87-105
170. Chomyn A., Attardi G. MtDNA mutations in aging and apoptosis. Biochem. Biophys. Res. Commun. 304:2003;519-529
171. Borowsky I.W., Collins R.C. Histochemical changes in enzymes of energy metabolism in the dentate gyrus accompany deafferentation and synaptic reorganization. Neuroscience. 33:1989;253-262
172. Wong-Riley M.T. Cytochrome oxidase: an endogenous metabolic marker for neuronal activity. Trends Neurosci. 12:1989;94-101
173. Parker W.D. Jr., Filley C.M., Parks J.K. Cytochrome oxidase deficiency in Alzheimer's disease. Neurology. 40:1990;1302-1303
174. Parker W.D. Jr., Mahr N.J., Filley C.M., Parks J.K., Hughes D., Young D.A., et al. Reduced platelet cytochrome c oxidase activity in Alzheimer's disease. Neurology. 44:1995;1086-1090
175. Bosetti F., Brizzi F., Barogi S., Mancuso M., Siciliano G., Tendi E.A., et al. Cytochrome c oxidase and mitochondrial F1F0=ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer's disease. Neurobiol. Aging. 23:2002;371-376
176. Cardoso S.M., Proenca M.T., Santos S., Santana I., Oliveira C.R. A possible mechanism for the decrease of cytochrome oxidase in Alzheimer's disease. Soc. Neurosci. Abstr. 25:1999;337
177. Mancuso M., Filosto M., Bosetti F., Ceravolo R., Rocchi A., Tognoni G., et al. Decreased platelet cytochrome c oxidase activity is accompanied by increased blood lactate concentration during exercise in patients with Alzheimer disease. Exp. Neurol. 182:2003;421-426
178. Curti D., Rognoni F., Gasparini L., Cattaneo A., Paolllo M., Racchi M., et al. Oxidative metabolism in cultured fibroblasts derived from sporadic Alzheimer's disease (AD) patients. Neurosci. Lett. 236:1997;13-16
179. Gabuzda D., Busciglio J., Chen L.B., Matsudaira P., Yankner B.A. Inhibition of energy metabolism alters the processing of amyloid precursor protein and induces a potentially amyloidogenic derivative. J. Biol. Chem. 269:1994;13623-13628
180. Webster M.T., Pearce B.R., Bowen D.M., Francis P.T. The effecs of perturbed energy metabolism on the processing of amyloid precursor protein in PC12 cells. J. Neural. Transm. 105:1998;839-853
181. +-ATPase activity in hippocampal neurons. Brain Res. 756:1997;205-214
182. Pereira C., Santos M.S., Oliveira C. Mitochondrial function impairment induced by amyloid beta-peptide on PC12 cells. Neuroreport. 9:1998;1749-1755
183. Canevari L., Clark J.B., Bates T.E. β -Amyloid fragment 25-35 selectively decreases complex IV activity in isolated mitochondria FEBS Lett. 457:1999;131-134
184. Blass J.P., Baker A.C., Ko L., Black R.S. Induction of Alzheimer antigens by an uncoupler of oxidative phosphorylation. Arch. Neurol. 47:1990;864-869
185. Zabar Y., Kawas C.H. Epidemiology and clinical genetics of Alzheimer's disease. Clark C.M., Trojanowski J.Q. Neurodegenerative dementias: clinical features and pathological mechanisms. 2000;79-94 McGraw-Hill, New York
186. Evans D.A., Funkenstein H.H., Albert M.S., Scherr P.A., Cook N.R., Chown M.J., et al. Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. JAMA. 262:1989;2551-2556
187. Swerdlow R.H. Role of mitochondria in Parkinson's disease. Chesselet M.F. Molecular mechanisms of neurodegenerative diseases. 2000;233-270 Humana Press Inc, New Jersey
188. Swerdlow R.H., Parks J.K., Pattee G., Parker W.D. Jr. Role of mitochondria in amyotrophic lateral sclerosis. Amyotroph. Lateral Sclerosis Motor Neuron Disorders. 1:2000;185-190